Abstract
Studies in myeloid neoplasms have described recurrent IDH1 and IDH2 mutations as primarily mutually exclusive. Over a 6-month period of clinical testing with a targeted next-generation sequencing assay, we evaluated 92 patients with acute myeloid leukemia, myelodysplastic syndrome, and chronic myelomonocytic leukemia and identified a subset of 21 patients (23%) who harbored mutations in either IDH1 or IDH2. Of the 21 patients with IDH mutations, 4 (19%) were found to have single nucleotide variants in both IDH1 and IDH2. An additional patient included in the study was found to have two different IDH2 mutations. The mutations were typically present at different variant allelic frequencies, with one predominating over the other, consistent with the presence of multiple subclones in a single patient. In one case, the variant allelic frequencies in both IDH1 and IDH2 were equally low in the setting of a high percentage of blasts, suggesting that the IDH mutations were unlikely to be present in the founding clone. Given these data, we conclude that dual IDH1/2 mutations likely were previously underestimated, a finding that may carry important treatment implications.
References
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Aug 7, 2009·The New England Journal of Medicine·Elaine R MardisTimothy J Ley
Feb 23, 2010·Cancer Cell·Patrick S WardCraig B Thompson
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guido MarcucciClara D Bloomfield
Apr 9, 2010·Leukemia·O KosmiderM Fontenay
Jun 23, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter PaschkaKonstanze Döhner
Dec 7, 2010·Cancer Cell·Maria E FigueroaAri Melnick
May 21, 2011·Blood·Claire L GreenRosemary E Gale
May 21, 2011·The Journal of Pathology·M Fernanda AmaryAdrienne M Flanagan
Dec 20, 2011·The Oncologist·Darrell R BorgerA John Iafrate
Feb 11, 2012·Brain Tumor Pathology·Motohiro AraiYoichi Nakazato
Mar 14, 2012·Briefings in Bioinformatics·Oscar WestessonIan Holmes
Mar 16, 2012·The New England Journal of Medicine·Jay P PatelRoss L Levine
Jul 24, 2012·Cell·John S WelchRichard K Wilson
Jul 26, 2012·BMC Genomics·Michael A QuailYong Gu
Feb 9, 2013·Science·Julie-Aurore LosmanWilliam G Kaelin
Feb 12, 2013·Nature Biotechnology·Kristian CibulskisGad Getz
Apr 6, 2013·Science·Dan RohleIngo K Mellinghoff
Apr 6, 2013·Science·Fang WangKatharine E Yen
Apr 20, 2013·The American Journal of Surgical Pathology·Darcy A KerrG Petur Nielsen
May 18, 2013·Cancer Cell·Christopher J PirozziHai Yan
Aug 21, 2013·Blood·Anuhar ChaturvediMichael Heuser
Sep 3, 2013·Haematologica·Tung-Liang LinLee-Yung Shih
Apr 25, 2014·The Oncologist·Amir T FathiDarrell R Borger
Oct 11, 2012·ACS Medicinal Chemistry Letters·Janeta Popovici-MullerShinsan M Su
Nov 11, 2014·Nature Medicine·Zongli ZhengLong Phi Le
Dec 10, 2014·Blood Cells, Molecules & Diseases·Sadudee ChotiratChirayu U Auewarakul
Citations
Mar 5, 2016·Surgical Pathology Clinics·Valentina Nardi, Robert P Hasserjian
Oct 11, 2016·Leukemia·B C MedeirosR Swords
Mar 16, 2018·Future Oncology·Guillermo Montalban-Bravo, Courtney D DiNardo
Oct 25, 2017·Current Hematologic Malignancy Reports·Brittany Knick Ragon, Courtney D DiNardo
Sep 6, 2017·Acta Haematologica·Na WangHongzhi Xu
Feb 24, 2019·Cancers·Michael LeischLisa Pleyer
Apr 21, 2020·Expert Review of Hematology·Xavier ThomasMaël Heiblig
Apr 2, 2020·Blood·Robert P HasserjianBenjamin L Ebert
Sep 2, 2020·Expert Review of Hematology·Juan Eduardo Megías-VericatPau Montesinos
Aug 28, 2019·Expert Opinion on Pharmacotherapy·Maria Ilaria Del PrincipeAdriano Venditti
Jun 9, 2018·Cancers·Michael J BuegeCourtney D DiNardo
Aug 30, 2020·Cancers·Ugo TestaElvira Pelosi
May 18, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria L Amaya, Daniel A Pollyea
Nov 17, 2019·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Ana Bela Sarmento-RibeiroIoannis P Trougakos
Sep 4, 2018·Clinical Biochemistry·Lucie PetrovaKaterina Hrochova
Aug 19, 2021·European Journal of Haematology·Amy SongMohammad O Hussaini
Oct 27, 2021·Biological Chemistry·Philipp MakowkaHubert Serve